FDA’s call for further review of pirfenidone disappointing for Pulmonary Fibrosis patients, says CPF
May 7, 2010 by biotechconnection.com · Leave a Comment
FDA’s call for further review of pirfenidone disappointing for Pulmonary Fibrosis patients, says CPF
The Coalition for Pulmonary Fibrosis (CPF), representing tens of thousands of patients, is responding to the news that the FDA chose to ask for further study of Pirfenidone, which will delay potential approval of the first drug in the treatment of Pulmonary [...]
Stakeholder Opinions Hematopoietic Stem Cell Transplantation In need of further research and development
March 8, 2010 by biotechconnection.com · Leave a Comment
Stakeholder Opinions Hematopoietic Stem Cell Transplantation In need of further research and development
Hematopoietic stem cell transplantation (HSCT) has evolved considerably over the past 50 years, driven by developments in stem cell sources, donor identification and conditioning regimens. Nowadays, it has a range of applications, including the treatment of certain hematologic malignancies. However, further research efforts [...]